Immunai Raises $60M to Decode the Immune System with Machine Learning and AI – AlleyWatch
Posted: February 20, 2021 at 7:45 pm
The immune system at its core is a complex system of cells, organs, and tissues. These components work in unison to fight infection in the form of microbes. Developing an understanding of how this intricate system works is critical in ensuring that society as a whole has adequate immune health to combat disease and infection.Immunaihas built the largest database for immunology in the world using machine learning and AI to map the entire immune system at a granular and specific level. This data can be leveraged by the healthcare industry to provide better therapeutics that get to market faster. This understanding will also allow biotech companies and pharmaceutical manufacturers to radically personalize therapeutics in the future. Immunai is initially focused on the oncology market but the offering is versatile can be applied to things like autoimmune disorders and infectious diseases like COVID-19.
AlleyWatch caught up with CEO and Cofounder Noam Solomon to learn more about the impact that Immunai is having in the understanding of the immune system, the companys partnerships, experience fundraising during the pandemic, latest funding round, and much, much more
Who were your investors and how much did you raise?
This $60M Series A round was led by Schusterman Family Investments, Duquesne Family Office, Catalio Capital Management, and Dexcel Pharma, with additional participation from existing investors Viola Ventures and TLV Partners.
Tell us about the product or service that Immunai offers.
Immunai is on a mission to reprogram the immune system to advance personalized medicine to better detect, diagnose, and treat disease. To do so, Immunai has generated the largest proprietary database for immunology in the world, known as the Annotated Multi-omic Immune Cell Atlas (AMICA). This platform incorporates variables such as clinical lab metadata (e.g., processing wait time) and batch data (e.g., hospital), and others; then, it leverages machine learning and artificial intelligence to complete the annotation and characterization of immune cells. Immunais team of computational biologists and immunologists work with our partners at pharmaceutical companies to figure out the implications of what Immunai has found, whether its a new therapy, a drug combination, or a diagnostic.
What inspired the start of Immunai?
When I met my cofounder Luis, I was a math postdoc at MIT and Luis was working to apply machine learning to biology. Together, we wanted to bring transfer learning AI methods to what we believe would solve the biggest problem in society today disease.
All disease can be traced back to the immune system. But what we realized is that pharmaceutical companies dont have access to any comprehensive, granular insight into how the immune system works, how it responds to the drugs or therapies theyre developing, and what patients are most likely to benefit. With our scientific cofounders, Ansu Satpathy (assistant professor at Stanford for cancer immunology), Danny Wells (researcher at the Parker Institute for cancer immunotherapy) and Dan Littman (Professor at NYU and HHMI investigator) we realized that with single-cell technologies we would be able to measure and map the immune system with granularity and specificity like never available before.
At Immunai, weve combined the brightest minds across single-cell genomics, data science, and engineering to build the largest proprietary database on immunology in the world. We hope our work will lead to a better understanding of how to overcome the key unsolved problems and bottlenecks in immunotherapy discovery and development. We want to enable the development of more effective therapies and combinations for each patient, accelerate the ability to bring these therapies to market, and ultimately, provide better options for patients at a faster pace than ever before.
How is Immunai different?
No one is doing exactly what were doing. Companies have been trying to understand the immune system for years, but have been limited by traditional bulk sequencing technologies, which dont provide nearly enough data. By analyzing gene expression levels, protein markers, TCR and BCR fragments, and other single-cell omics, weve compiled 10,000 times more data for each immune cell than others before, giving partners a view of the immune system with a full spectrum of color and dimensionality.
Further, our proprietary machine learning and single-cell analysis that we apply to mine AMICA , the worlds largest proprietary Multiomic Immune Cell Atlas, allow us to understand the immune system at scale with unprecedented granularity and consistency. This provides a solution to the prohibitive batch effect problem that our competitors have not been able to solve.
What market does Immunai target and how big is it?
Immunais offering can be applied to multiple disease areas from cancer to autoimmune disorders to infectious diseases like COVID-19. The company is primarily focusing on the oncology market, which is currently set to surpass $469.5 billion by 2026.
Whats your business model?
Immunai partners with biopharmaceutical and biotech companies to answer critical questions like what makes T-cells expand, persist, and penetrate a tumor, which cells are cytotoxic, which cells in a cell therapy drive response, what are the immunological signatures that are more likely to lead to clinical response to different therapies, and more. These partnerships are usually structured as milestone-based collaborations, ranging from prospective clinical trial design and biomarker discovery to earlier target discovery and target validation.
How has COVID-19 impacted your business?
COVID-19 has impacted the way we work and the pace at which we work. Weve asked our employees who are not working in the lab to work from home and have implemented strict social distancing protocols within the lab. In the biopharma world, business is bigger than ever before, so we have many new partnerships in a variety of disease areas, including Immuno-Oncology, Autoimmunity, Neurodegenerative diseases, and infectious diseases .
What was the funding process like?
Fast but complex. It happened over a few very eventful months, with many important partnerships forged and multiple parties involved in the financing round, which all took place during a worldwide pandemic, of course.
What are the biggest challenges that you faced while raising capital?
The financing round happened as we were closing a few important partnerships, so running both responsibilities as CEO was non-trivial. In the middle of it all, life happened, and we had to deal with family health issues, including the fact that my wife and I had caught COVID, but we were both fine, luckily.
But what I didnt expect from the pandemic was being able to raise $60M without meeting the lead investors face to face. This is something that frankly, I didnt expect happening, and definitely didnt expect would happen so fast.
What factors about your business led your investors to write the check?
Our investors have witnessed the accelerated growth of our platform and are aligned with our vision to reprogram immunity. Machine learning crossed with genomics will unlock the mysteries of the immune system and lead to improved therapies. To actually execute on this vision, a world-class team is required, and weve put it together.
What are the milestones you plan to achieve in the next six months?
Were going to use this new financing round to build and improve our platform. With our expansion into functional genomics, well be funding collaborations with partners to answer the most pressing questions in immuno-oncology, cell therapy, infectious disease, and autoimmunity, including key biology driving clinical endpoints and target discovery.
We also plan to invest heavily in growth and double our team of 70 by year-end. We currently have a large lab in New York with 50 scientists working on sequencing and tech development. Were looking to add more people to the team to develop new assets and IP.
We also plan to invest heavily in growth and double our team of 70 by year-end. We currently have a large lab in New York with 50 scientists working on sequencing and tech development. Were looking to add more people to the team to develop new assets and IP.
What advice can you offer companies in New York that do not have a fresh injection of capital in the bank?
Understand the essence of what youre building and bring it to market quickly. Lean Startup is one of the most important business books Ive read; its critical for any business, but particularly for one with a limited runway. Whats the most expeditious experiment you can run to see if your customers actually care about your product.
Where do you see the company going now over the near term?
Were transitioning from observational genomics to functional genomics. Were concentrating on two major projects: improving the ability to target new checkpoints and validate targets for cell therapies. Just in the last year, weve been able to identify new mechanisms of resistance with partners in record time. At this pace, we hope the work well be able to do in the next couple of years will be groundbreaking and life-saving, but its too early to say specifically where well be.
Whats your favorite outdoor dining restaurant in NYC
Cafe Mogador on St Marks.
Excerpt from:
Immunai Raises $60M to Decode the Immune System with Machine Learning and AI - AlleyWatch
- Getting Started With Machine Learning: Definition and Applications - CMSWire - February 20th, 2021
- This Biotech Company Combines Single Cell Genomics with Machine Learning (ML) Algorithms To Enable High Resolution Profiling of the Immune System -... - February 20th, 2021
- Cloud Machine Learning Market: Indoor Applications Projected to be the Most Attractive Segment during 2021-2029 KSU | The Sentinel Newspaper - KSU |... - February 20th, 2021
- Machine Learning in Insurance Market: Indoor Applications Projected to be the Most Attractive Segment during 2021-2029 KSU | The Sentinel Newspaper -... - February 20th, 2021
- Carin Meier Using Machine Learning to Combat Major Illness, such as the Coronavirus - InfoQ.com - February 20th, 2021
- Moffitt Cancer Center: Why we are building the first machine learning department in oncology - The Cancer Letter - February 20th, 2021
- Machine Learning and where is it used? - Tech Guide - February 20th, 2021
- Artificial Intelligence and Machine Learning for Insurance Technology from Johnson Controls Available on the Ocean Tomo Bid-Ask Market - Yahoo Finance - February 20th, 2021
- Identifying COVID-19 Therapy Candidates With Machine Learning - Contagionlive.com - February 20th, 2021
- Machine Learning in Tax and Accounting Market gigantic revenues by 2028 with Amazon Web Services, Baidu Inc, Google, Intel, IBM, Hewlett Packard,... - February 20th, 2021
- Using AI and Machine Learning will increase in horti industry - hortidaily.com - February 13th, 2021
- The head of JPMorgan's machine learning platform explained what it's like to work there - eFinancialCareers - February 13th, 2021
- If you know nothing about deep learning with Python, start here - TechTalks - February 13th, 2021
- Mental health diagnoses and the role of machine learning - Health Europa - February 13th, 2021
- 5 Ways the IoT and Machine Learning Improve Operations - BOSS Magazine - February 13th, 2021
- There Is No Silver Bullet Machine Learning Solution - Analytics India Magazine - February 13th, 2021
- Postdoctoral Research Associate in Digital Humanities and Machine Learning job with DURHAM UNIVERSITY | 246392 - Times Higher Education (THE) - February 13th, 2021
- The Collision of AI's Machine Learning and Manipulation: Deepfake Litigation Risks to Companies from a Product Liability, Privacy, and Cyber... - February 13th, 2021
- Parascript and SFORCE Partner to Leverage Machine Learning Eliminating Barriers to Automation - GlobeNewswire - February 13th, 2021
- Rackspace Technology Study uncovers AI and Machine Learning knowledge gap in the UAE - Intelligent CIO ME - February 13th, 2021
- How Blockchain and Machine Learning Impact on education system - ABCmoney.co.uk - February 13th, 2021
- Mission Healthcare of San Diego Adopts Muse Healthcare's Machine Learning Tool - Southernminn.com - January 19th, 2021
- Deep Learning Outperforms Standard Machine Learning in Biomedical Research Applications, Research Shows - Georgia State University News - January 19th, 2021
- Project MEDAL to apply machine learning to aero innovation - The Engineer - January 19th, 2021
- Forecast On Machine Learning (ML) Intelligent Process Automation Market Witness the Growth of Great Billion by 2027 With Top Companies Like Automation... - January 19th, 2021
- Machine Learning Shown to Identify Patient Response to Sarilumab in Rheumatoid Arthritis - AJMC.com Managed Markets Network - January 19th, 2021
- Bangalore based Great Learning can help you unleash the potential of an M-Tech in Data Science & Machine - Times of India - January 19th, 2021
- CERC plans to embrace AI, machine learning to improve functioning - Business Standard - January 19th, 2021
- NTT Co-authored Papers at NeurIPS to Advance Machine Learning Efficiency and Performance - Business Wire - December 7th, 2020
- Why Intel believes confidential computing will boost AI and machine learning - VentureBeat - December 3rd, 2020
- Machine Learning Market to Grow Notably Attributed to Increasing Adoption of Analytics-driven Solutions by Developing Economies, says Fortune Business... - December 3rd, 2020
- Machine learning: The new language of data and analytics - ITProPortal - December 3rd, 2020
- Injecting Machine Learning And Bayesian Optimization Into HPC - The Next Platform - December 3rd, 2020
- QA Increasingly Benefits from AI and Machine Learning - RTInsights - December 3rd, 2020
- Everything to Know About Machine Learning as a Service (MLaaS) - Analytics Insight - December 3rd, 2020
- How the Food and Beverage Industry is Affected by Machine Learning and AI - IoT For All - December 3rd, 2020
- Amazon announces new machine learning tools to help customers monitor machines and worker safety - www.computing.co.uk - December 3rd, 2020
- Machine Learning and Location Data Applications Market 2020 Top Companies report covers, Industry Outlook, Top Countries Analysis & Top... - December 3rd, 2020
- Commentary: Chain of Demand applies AI, machine learning to retail supply chain profitability - FreightWaves - December 3rd, 2020
- Machine learning - it's all about the data - KHL Group - December 3rd, 2020
- Product Portfolio Analysis and Technological Development of Machine Learning in Medical Imaging Market during the forecasted period - Murphy's Hockey... - December 3rd, 2020
- Imaging AI and Machine Learning Beyond the Hype, Upcoming Webinar Hosted by Xtalks - PR Web - December 3rd, 2020
- Veritone aiWARE Now Supports NVIDIA CUDA for GPU-based AI and Machine Learning - Business Wire - December 3rd, 2020
- Exactech Launches Predict+, First Machine Learning-Based Software that Informs Surgeons with Patient-Specific Outcomes Predictions After Shoulder... - December 3rd, 2020
- How To Choose The Best Machine Learning Algorithm For A Particular Problem? - Analytics India Magazine - October 19th, 2020
- Lantronix Brings Advanced AI and Machine Learning to Smart Cameras With New Open-Q 610 SOM Based on the Powerful Qualcomm QCS610 System on Chip (SOC)... - October 19th, 2020
- AI and Machine Learning Technologies Expected to Play a Key Role in Expanding Multi Billion Dollar Digital Banking Sector: Report - Crowdfund Insider - October 19th, 2020
- AutoML Alleviates the Process of Machine Learning Analysis - Analytics Insight - October 19th, 2020
- Futurism Reinforces Its Next-Gen Business Commerce Platform With Advanced Machine Learning and Artificial Intelligence Capabilities - Yahoo Finance - October 19th, 2020
- Purebase Enhances Its Board of Advisors with An Expert on Machine Learning and Cheminformatics - GlobeNewswire - October 19th, 2020
- COVID-19 And The Role Of AI, Machine Learning In Logistics: A Conversation With Delhivery CTO Kapil Bharati - Mashable India - October 19th, 2020
- How to Beat Analysts and the Stock Market with Machine Learning - Knowledge@Wharton - October 19th, 2020
- AI and Machine Learning Can Help Fintechs if We Focus on Practical Implementation and Move Away from Overhyped Narratives, Researcher Says - Crowdfund... - October 19th, 2020
- Proximity matters: Using machine learning and geospatial analytics to reduce COVID-19 exposure risk - Healthcare IT News - September 20th, 2020
- PREDICTING THE OPTIMUM PATH - Port Strategy - September 20th, 2020
- What is 'custom machine learning' and why is it important for programmatic optimisation? - The Drum - September 20th, 2020
- How Machine Learning is Set to Transform the Online Gaming Community - Techiexpert.com - TechiExpert.com - September 20th, 2020
- Current and future regulatory landscape for AI and machine learning in the investment management sector - Lexology - September 20th, 2020
- Global Machine Learning Courses Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries -... - September 20th, 2020
- When AI in healthcare goes wrong, who is responsible? - Quartz - September 20th, 2020
- Is Wide-Spread Use of AI & Machine Intelligence in Manufacturing Still Years Away? - Automation World - September 20th, 2020
- How do we know AI is ready to be in the wild? Maybe a critic is needed - ZDNet - September 20th, 2020
- Solving the crux behind Apple's Silicon Strategy - Medium - September 20th, 2020
- Boost Your Animation To 60 FPS Using AI - Hackaday - September 20th, 2020
- 50 Latest Data Science And Analytics Jobs That Opened Last Week - Analytics India Magazine - September 20th, 2020
- Algorithms may never really figure us out thank goodness - The Boston Globe - September 20th, 2020
- Why Deep Learning DevCon Comes At The Right Time - Analytics India Magazine - September 20th, 2020
- Six notable benefits of AI in finance, and what they mean for humans - Daily Maverick - September 20th, 2020
- Twitter is looking into why its photo preview appears to favor white faces over Black faces - The Verge - September 20th, 2020
- 8 Trending skills you need to be a good Python Developer - iLounge - September 20th, 2020
- Automation Continuum - Leveraging AI and ML to Optimise RPA - Analytics Insight - September 20th, 2020
- UT Austin Selected as Home of National AI Institute Focused on Machine Learning - UT News | The University of Texas at Austin - August 27th, 2020
- Participation-washing could be the next dangerous fad in machine learning - MIT Technology Review - August 27th, 2020
- Getting to the heart of machine learning and complex humans - The Irish Times - August 27th, 2020
- Air Force Taps Machine Learning to Speed Up Flight Certifications - Nextgov - August 27th, 2020
- The Role of Artificial Intelligence and Machine Learning in the... - Insurance CIO Outlook - August 27th, 2020
- AI and Machine Learning Network Fetch.ai Partners Open-Source Blockchain Protocol Waves to Conduct R&D on DLT - Crowdfund Insider - August 27th, 2020
- AI may not predict the next pandemic, but big data and machine learning can fight this one - ZDNet - August 27th, 2020
- Machine Learning Artificial intelligence Market Size and Growth By Leading Vendors, By Types and Application, By End Users and Forecast to 2020-2027 -... - August 27th, 2020
- Explainable AI: From the peak of inflated expectations to the pitfalls of interpreting machine learning models - ZDNet - August 27th, 2020